User Profile
Corporate
Careers
FAQ
Blog
Pricing
Social
General Modals
Advanced Modals
Search
Wizards
Melanoma Research Foundation Breakthrough Consortium (MRFBC) Pilot Translational Award
The Melanoma Research Foundation’s Breakthrough Consortium (MRFBC) is releasing this RFP to fund a one-year pilot proposal for $50,000 to focus on clinical/translational research. As this is a pilot award, preliminary data is not required. Successful applications will emphasize novel, innovative translational proposals focused on clinical/translational research. This grant is not to support a clinical trial; however, this award could support correlative or bioinformatic work that accompanies a clinical trial. The goal of the pilot proposal should be to create findings that could then lend themselves to larger, multicenter grant proposals. A
Specialties
Eligibility Requirements
• Applications must focus on an aspect of melanoma research.
• Applications must propose translational or clinical work that utilizes human specimens (e.g., blood, tissue, etc.), macromolecules derived from human tissue (e.g., RNA, DNA, protein), or patient reported outcome measures. Please note: this grant is not to support the conduct of a clinical trial; however, it could support correlative or bioinformatic work that accompanies a clinical trial. Further, although patient-derived xenograft work would be eligible for funding, work conducted solely on tissue culture cell lines would not be eligible. • Successful applications will detail how their findings may lend themselves to larger, multicenter grant proposals.
• Applicants must hold a PhD or MD degree or equivalent at the time of submission.
• Applicants can be post-doctoral and/or research fellows, research associates/scientists, instructors, or professors (either assistant, associate, or full) at the time of submission. Both tenured and non- tenured track faculty are encouraged to apply.
• Any associate or full professors that apply MUST include a more junior faculty member (at any level) as part of the application.
• The grant applicant (PI) must be from a MRFBC institution. Co-PIs/ key personnel may be from non- MRFBC sites. A list of the MRFBC institutions can be found on the MRF website.
• American citizenship is not required. However, the proposed research must be conducted in a non- profit research organization, medical institution, or educational institution located in the United States
. • Proposed research cannot be identical to a currently awarded MRF grant. Further, 1 applicants are eligible to respond to other MRF RFPs, as long as the research proposals are significantly different.
• Proposed research must comply with all applicable National Institutes of Health (NIH) animal and human welfare guidelines
. • Applicants are encouraged to discuss any eligibility questions with the MRF prior to submitting an application.
Eligible Countries:
Sponsor Details
Sponsor Institute/Organizations: Melanoma Research Foundation (MRF)
Address: Melanoma Research Foundation 1420 K Street NW, 7th Floor Washington, DC 20005
Legal & Affiliation Disclaimer
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Award
Final Deadline:
Mar 31, 2025
Funding Amount:
$50,000
Host Details
Affiliation: Melanoma Research Foundation (MRF)
Address: Melanoma Research Foundation 1420 K Street NW, 7th Floor Washington, DC 20005
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.
Invite Gmail Contacts